Decreased Levels of Apolipoprotein A-I in Plasma of Schizophrenic Patients

Overview

Journal J Neural Transm (Vienna)

Specialties Neurology
Physiology

Date 2006 Dec 14

PMID 17165100

Citations 17

Authors

Y J La

C L Wan

H Zhu

Y F Yang

Y S Chen

Y X Pan

G Y Feng

L He

Affiliations

Soon will be listed here.

Abstract

This study aims to identify the effects of antipsychotics on plasma proteins, and on the proteins associated with schizophrenia. We applied proteomics technology to screen protein aberrations in Sprague-Dawley rats treated with antipsychotics and schizophrenic patients undergoing medication. ApoA-I was found significantly increased in the chlorpromazine-treated rats and decreased in the patients with treatment-resistant schizophrenia, which suggest that decreased levels of apoA-I might be associated with the pathology of schizophrenia and that chlorpromazine increases apoA-I levels as part of its therapeutic action.

Citing Articles

The Variants at nd Contribute to the Susceptibility of Schizophrenia With Inhibiting mRNA Expression in Peripheral Blood Leukocytes.

Fan Y, Gao J, Li Y, Chen X, Zhang T, You W Front Mol Biosci. 2021; 8:785445.

PMID: 34938775 PMC: 8685515. DOI: 10.3389/fmolb.2021.785445.

Association Between ApoA1 Gene Polymorphisms and Antipsychotic Drug-Induced Dyslipidemia in Schizophrenia.

Fan L, You Y, Fan Y, Shen C, Xue Y Neuropsychiatr Dis Treat. 2021; 17:1289-1297.

PMID: 33958870 PMC: 8096449. DOI: 10.2147/NDT.S305200.

Bacterial DNA induces the formation of heat-resistant disease-associated proteins in human plasma.

Tetz V, Tetz G Sci Rep. 2019; 9(1):17995.

PMID: 31784694 PMC: 6884558. DOI: 10.1038/s41598-019-54618-9.

Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia.

Boiko A, Mednova I, Kornetova E, Semke A, Bokhan N, Loonen A Heliyon. 2019; 5(7):e02033.

PMID: 31317083 PMC: 6611937. DOI: 10.1016/j.heliyon.2019.e02033.

Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots.

Cooper J, Ozcan S, Gardner R, Rustogi N, Wicks S, van Rees G Transl Psychiatry. 2017; 7(12):1290.

PMID: 29249827 PMC: 5802534. DOI: 10.1038/s41398-017-0027-0.

References

Lewis C, Levinson D, Wise L, DeLisi L, Straub R, Hovatta I . Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet. 2003; 73(1):34-48. PMC: 1180588. DOI: 10.1086/376549. View

Eubanks J, Djabali M, Selleri L, Grandy D, Civelli O, McElligott D . Structure and linkage of the D2 dopamine receptor and neural cell adhesion molecule genes on human chromosome 11q23. Genomics. 1992; 14(4):1010-8. DOI: 10.1016/s0888-7543(05)80124-7. View

Bassett A . Chromosomal aberrations and schizophrenia. Autosomes. Br J Psychiatry. 1992; 161:323-34. PMC: 3188307. DOI: 10.1192/bjp.161.3.323. View

Bell F, Hubert E . Membrane-active agents. Effect of various anesthetics and chlorpromazine on arterial lipid metabolism. Atherosclerosis. 1981; 39(4):517-25. DOI: 10.1016/0021-9150(81)90009-5. View

Khan M, Parikh V, Mahadik S . Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. J Neurochem. 2003; 86(5):1089-100. DOI: 10.1046/j.1471-4159.2003.01866.x. View

Spitzer R, Williams J, GIBBON M, First M . The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry. 1992; 49(8):624-9. DOI: 10.1001/archpsyc.1992.01820080032005. View

Thomas E, Dean B, Scarr E, Copolov D, Sutcliffe J . Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder. Mol Psychiatry. 2003; 8(2):167-75. DOI: 10.1038/sj.mp.4001223. View

Liu W, Breen G, Zhang J, Li S, Gu N, Feng G . Association of APOE gene with schizophrenia in Chinese: a possible risk factor in times of malnutrition. Schizophr Res. 2003; 62(3):225-30. DOI: 10.1016/s0920-9964(02)00384-5. View

Dean B, Laws S, Hone E, Taddei K, Scarr E, Thomas E . Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia. Biol Psychiatry. 2003; 54(6):616-22. DOI: 10.1016/s0006-3223(03)00075-1. View

10.

Mahadik S, Khan M, Evans D, Parikh V . Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome. Schizophr Res. 2002; 58(1):55-62. DOI: 10.1016/s0920-9964(01)00378-4. View

11.

La Y, Wan C, Zhu H, Yang Y, Chen Y, Pan Y . Hippocampus protein profiling reveals aberration of malate dehydrogenase in chlorpromazine/clozapine treated rats. Neurosci Lett. 2006; 408(1):29-34. DOI: 10.1016/j.neulet.2006.05.026. View

12.

Gurling H, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo B . Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet. 2001; 68(3):661-73. PMC: 1274479. DOI: 10.1086/318788. View

13.

Kartelishev A, Kolupaev G, Kliuzhev V, Lakosina N, Vernekina N, Chebotkov A . [Pathology and chemical verification and detection of "risk group" of endogenous psychosis]. Voen Med Zh. 2003; 324(3):60-4. View

14.

Wen F, Tan J . Effects of phenothiazine drugs on serum levels of apolipoproteins and lipoproteins in schizophrenic subjects. Acta Pharmacol Sin. 2003; 24(10):1001-5. View

15.

Eder-Ischia U, Ebenbichler C, Fleischhacker W . Olanzapine-induced weight gain and disturbances of lipid and glucose metabolism. Essent Psychopharmacol. 2005; 6(2):112-7. View

16.

Saari K, Jokelainen J, Veijola J, Koponen H, Jones P, Savolainen M . Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey. Acta Psychiatr Scand. 2004; 110(4):279-85. DOI: 10.1111/j.1600-0447.2004.00358.x. View

17.

Meng Q, Bergeron J, Sparks D, Marcel Y . Role of apolipoprotein A-I in cholesterol transfer between lipoproteins. Evidence for involvement of specific apoA-I domains. J Biol Chem. 1995; 270(15):8588-96. DOI: 10.1074/jbc.270.15.8588. View

18.

Jiang L, Lindpaintner K, Li H, Gu N, Langen H, He L . Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia. Amino Acids. 2003; 25(1):49-57. DOI: 10.1007/s00726-003-0356-6. View

19.

Thomas E, Dean B, Pavey G, Sutcliffe J . Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc Natl Acad Sci U S A. 2001; 98(7):4066-71. PMC: 31180. DOI: 10.1073/pnas.071056198. View

20.

. Actions of chlorpromazine, haloperidol and pimozide on lipid metabolism in guinea pig brain slices. Biochem Pharmacol. 1980; 29(19):2697-700. DOI: 10.1016/0006-2952(80)90092-1. View